关于我们

Company profile

Organizational structure

Honors

Our history

Party branch

Activities

Subsidiaries

Return

Subsidiaries

Deren Medicine, a wholly-owned subsidiary of Tianzheng, set up with 6 mln yuan registered capital and business scope ranging from wholesale of Chinese proprietary medicines, chemosynthetic drug, antibiotics, biological products (excl vaccine), anabolic hormones, peptide hormones, health food, medical equipment, medical disinfectant, medical supplies and equipment, disinfection supplies, food, daily necessities, household appliances, cosmetics, hygiene products, medicine and medical consulting services, to import and export trade permitted by laws and regulations. On 6th Dec 2018, the 18th session of board meeting agreed the proposal for acquiring 100% equity of Deren Medicine. On 21th Dec 2018, the 10th session of general meeting of shareholders adopted the proposal.

  

 

Sinopharm Medicine, a controlling subsidiary of Tianzheng, set up with 10 mln yuan registered capital and business scope ranging from wholesale of Chinese proprietary medicines, chemosynthetic drug, antibiotics, biological products (excl vaccine), anabolic hormones, peptide hormones, biochemical drugs, medical equipment, wholesale of health food,transportation of general goods, to import and export trade permitted by laws and regulations. On 21th Nov 2017, the 2nd session of board meeting agreed the proposal for acquiring 60% equity of Sinopharm Medicine. On 7th Dec 2017, the 9th session of general meeting of shareholders adopted the proposal.

 

 

Tianzheng Health Technology, a controlling subsidiary of Tianzheng, set up on 9th May 2020 with 10 mln registered capital and focus on development and production of FSMP, healthcare products, functional food and its active ingredient. On 8th Feb 2021, our board meeting agreed the proposal for acquiring Rezan Draft Fan Manufacturing, a move that increased the registered capital of Tianzheng Health Technology to 25 mln yuan after acquisition.  

 

 

 

New Land Fertilizer, a joint-stock company, set up on August 1st, 2018, with 10 mln yuan registered capital and focusing on production and marketing of fertilizer (bio-organic fertilizer, organic/inorganic compound fertilizer, blended fertilizer, BB fertilizer).